Development and Validation of HPTLC Method for Estimation of Propranolol Hydrochloride and Flunarizine Dihydrochloride in Combined Dosage Form

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Sample</td><td align="center">Peak purity</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">PRO</td><td align="center">0.998</td></tr><tr><td align="left">PRO formulation</td><td align="center">0.995</td></tr><tr><td align="left">FLU</td><td align="center">0.997</td></tr><tr><td align="left">FLU formulation</td><td align="center">0.994</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Peak purity correlation results of PRO and FLU in given formulations.

International Scholarly Research Notices

tab4

Table 4

Table 4: Development and Validation of HPTLC Method for Estimation of Propranolol Hydrochloride and Flunarizine Dihydrochloride in Combined Dosage Form 

Table 4 | Development and Validation of HPTLC Method for Estimation of Propranolol Hydrochloride and Flunarizine Dihydrochloride in Combined Dosage Form 